The 'unicorn or bust' model of venture capital ... there's a fresh movement to reconsider the role of venture capital in fueling startup journeys en route to profitability, acquisition or going ...
This year is shaping up to be the year when applied AI solutions demonstrate their long-term commercial value at scale.
Victor Basta, Managing Partner of Artis Partners, believes we may be in the midst of the next round of "Zombie Unicorns." ...
Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback